BCAX

COM:BICARA

Bicara Inc.

  • Stock

Last Close

19.32

20/11 21:00

Market Cap

802.06M

Beta: -

Volume Today

361.03K

Avg: -

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The ...Show More

investor of

competitor of